Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 3/20 | 0.51 |
| ▸ | CSNK2B | P67870 | 3/20 | 0.51 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 1/20 | 0.40 |
| ▸ | PLG | P00747 | 1/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | PLAT | P00750 | 1/20 | 0.40 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4368683 | 1.00 | CSNK2A2 (0.51) | CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2 | |
| SCHEMBL834188 | 0.87 | CSNK2A2 (0.52) | CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2 | |
| SCHEMBL2650490 | 0.86 | ALDH1A1 (0.56) | CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2 | |
| SCHEMBL2650488 | 0.86 | ALDH1A1 (0.56) | CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2 | |
| SCHEMBL832923 | 0.79 | CSNK2A2 (0.48) | CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2 | |
| SCHEMBL832924 | 0.79 | CSNK2A2 (0.48) | CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2 | |
| SCHEMBL10897969 | 0.73 | CSNK2A2 (0.65) | CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2 | |
| SCHEMBL5814507 | 0.71 | CSNK2A2 (0.55) | CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2 | |
| SCHEMBL11127621 | 0.71 | CSNK2A2 (0.60) | CSNK2A2CSNK2BCSNK2A1ALDH1A1PLCG2 | |
| SCHEMBL4365406 | 0.71 | KMT2A (0.58) | CSNK2A2CSNK2BCSNK2A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1908466-B1 | SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | DAIICHI SANKYO CO LTD (JP) | 2014-02-19 | — | — | EP | disclosed |
| US-8344029-B2 | Substituted propanamide derivative and pharmaceutical composition containing the same | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-01-01 | — | — | US | disclosed |
| US-20090292024-A1 | SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-11-26 | — | — | US | disclosed |
| EP-1908466-A1 | SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | Daiichi Sankyo Company, Limited (JP) | 2008-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090292024-A1 | SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | PTMS, C1S, ACP3 | CSNK2A2 1964/4885CSNK2B 1639/4885CSNK2A1 1601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.